In August, the company's predecessor, Qufu Focuschem Trading Co.,Ltd., was established.
In March, Shandong Focuschem Biotech Co.,Ltd. was formally established.
In April, the company successfully completed the shareholding reform and officially changed its name to Shandong Focuschem Biotech Co.,Ltd. In August, the first core employee equity incentive was completed. In September, it was identified as Jining Functional Polysaccharide Engineering Laboratory. In November, it was identified as Jining Biopolysaccharide Engineering Technology Research Center. In December, it was identified as a "national high-tech enterprise".
In May, the company completed the A round of financing of 25 million, and took the company's first step towards capitalization. In September, the Health Food Department was established. In December, the company established industry-university-research cooperation with Jiangnan University and Qufu Normal University. Recognized as the "hidden champion" of small and medium-sized enterprises in Shandong Province. Completed the second core employee equity incentive.
In January, the company established industry-university-research cooperation with Jining University. Obtained EFfCl GMP certification in February. Focus Bio-Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Focus Bio, was established. Obtained a food production license in May. Obtained 1 million yuan of funds for the introduction of urgently needed talents in key areas of Shandong Province. Recognized as Jining Enterprise Technology Center. In July, the company received 60 million M&A intentions from Freda Pharmaceuticals Group. In November, he won the third prize of the 7th Innovation and Entrepreneurship Competition of "Chuangda Cup" in Jining City. Recognized as the "One Enterprise One Technology" R&D Center in Shandong Province. The company donated 100,000 yuan to the education foundation of Xizou Town, Qufu City. In December, the company's independent research and development of "fermented sodium hyaluronate and Tremella polysaccharide key technology" was rated as a technological innovation project in Shandong Province, and won the second prize of Shandong Province Technology Innovation Award.
In February, the company and its employees donated a total of 209,000 yuan to the village and town epidemic prevention headquarters and the Municipal Charity Federation to fight the epidemic. In March, Focus Bio-Pharmaceutical Co., Ltd. launched a new production line of disposable medical masks to help global epidemic prevention and control. In April, the technological research on the high-yield sodium hyaluronate of Streptococcus zooepidemicus and the key preparation technology of the natural extract Tremella polysaccharide were rated as the international advanced level by the Shandong Fermentation Industry Association, and won the second prize for technological innovation in Shandong Province. In May, the company established school-enterprise cooperation with Qilu University of Technology.
In January, Focus Bio-Pharmaceutical Co., Ltd. obtained the raw material production license for sodium hyaluronate. Focus Biopharmaceutical Co., Ltd. obtained a cosmetic production license. In March, it won the Technology and Science and Technology Progress Award of Shandong Biological Fermentation Industry Association. In April, it was identified as "Shandong Postdoctoral Innovation Practice Base". Focus Biopharmaceutical Co., Ltd. was identified as "Jining One Enterprise One Technology R&D Center". In May, it was selected as a high-end brand cultivation enterprise in Shandong Province. In August, it was selected as the third batch of national-level specialized and special new "little giant" enterprises and national key "little giant" enterprises.
Shandong Focuschem Biotech Co.,Ltd.was changed to Shandong BaifuFreda Pharmaceutical Co., Ltd. FebruaryThe company won the title of exemplary organization of Scientific and Technological Innovation of Forida Pharmaceutical Group in 2021. April-Focus Biomedical Co., Ltd. has won the Chinese Patent Excellence Award for its invention patent "A method for preparing instant sodium hyaluronate". May - Shandong Focuschem Biotech Co.,Ltd.has officially changed its name to Shandong BaifuFreda Pharmaceutical Co., Ltd. July-Shandong BaifuFreda Pharmaceutical Co., Ltd. has been awarded the title of "specialized, refined, and innovative" small and medium-sized enterprise in Shandong Province. August-A eye protection food containing goji berries, sodium hyaluronate, and tea seed oil, as well as its preparation method and application, has officially obtained a national invention patent. September-Selected as a National Intellectual Property Advantage Enterprise in 2022. October-Selected for the 2022 Shandong Province service-oriented manufacturing demonstration list.Selected for the 2022 Shandong Province Science and Technology Small and Medium sized Enterprise Innovation Ability Enhancement Project (Second Batch). November-Selected as the seventh batch of national level manufacturing single champion enterprises.Selected as one of the first batch of technology giant enterprises in Shandong Province in 2022.Melatonin capsules and vitamin E soft capsules were selected for the 2022 Shandong Province Featured High Quality Food Catalogue product list. December-The "BOYO" series products and the "Jiamei Doctor" series products have been recognized as well-known brands in Shandong.
April-The focus of Jining Medical College's "Practical Teaching Base" landing is Forida. June-Obtaining CEP certificate for raw materials. July-The invention patent for "Preparation Method and Application of Astaxanthin Hyaluronic Acid Ester and Micelle" was successfully granted.The development of industrial technology for producing sodium hyaluronate from Streptococcus zoonoticus has won the first prize of the National Commercial Science and Technology Progress Award of the China Federation of Commerce. August-Baifu Forida was awarded the honorary title of "2023 Jining Gazelle Enterprise". In September, Focusfreda obtained the first domestic “Ergothioneine Group Standard” October, "Eye Drop grade Sodium hyaluronate API" by Focusfreda obtained CDE "I" status registration number.